Aligos Therapeutics Appoints Bridget Martell, MA, M.D., to its Board of Directors

by NASDAQ Market News November 18, 2021

NASDAQ Market News
Click here to email author

GENFIT: FNIH NIMBLE Study Demonstrates NIS4® Technology’s Unique Performance in Identifying Patients with “at-risk” NASH

Connect Biopharma Reports Positive Top-Line Results from the Global Phase 2 Clinical Trial of CBP-201 in Patients with Moderate-to-Severe Atopic Dermatitis

Ads